DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 208 filers reported holding DENALI THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,313,184 | -87.4% | 56,554 | -88.9% | 0.01% | -86.5% |
| Q1 2024 | $10,435,754 | +146.1% | 508,565 | +157.4% | 0.10% | +108.7% |
| Q4 2023 | $4,240,153 | -75.9% | 197,584 | -76.8% | 0.05% | -77.7% |
| Q3 2023 | $17,566,218 | +430.5% | 851,489 | +658.8% | 0.21% | +428.2% |
| Q2 2023 | $3,311,376 | +43.3% | 112,212 | +11.9% | 0.04% | +25.8% |
| Q1 2023 | $2,311,165 | -83.0% | 100,311 | -77.4% | 0.03% | -83.8% |
| Q3 2022 | $13,634,000 | +156.0% | 444,256 | +145.5% | 0.19% | +132.9% |
| Q2 2022 | $5,326,000 | -35.5% | 180,972 | -29.5% | 0.08% | -38.8% |
| Q1 2022 | $8,257,000 | +253.0% | 256,678 | +389.3% | 0.13% | +294.1% |
| Q4 2021 | $2,339,000 | – | 52,454 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $404,042,000 | 54.41% |
| Bratton Capital Management, L.P. | 953,035 | $19,785,000 | 29.05% |
| Flagship Pioneering Inc. | 8,005,747 | $166,199,000 | 7.19% |
| Casdin Capital, LLC | 400,000 | $8,304,000,000 | 0.78% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $91,561,000 | 0.65% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 22,595 | $469,000 | 0.37% |
| MARK ASSET MANAGEMENT LP | 70,532 | $1,464,000 | 0.34% |
| Artal Group S.A. | 400,000 | $8,304,000 | 0.34% |
| PIER 88 INVESTMENT PARTNERS LLC | 27,650 | $574,000 | 0.24% |
| WASATCH ADVISORS LP | 996,147 | $20,680,000 | 0.20% |